Atherosclerosis risk in women with polycystic ovarian syndrome: it’s not just the comorbidities - Top-Institutions - MDSpire

Atherosclerosis risk in women with polycystic ovarian syndrome: it’s not just the comorbidities

  • By

  • Katharine A Bate

  • Gemma A Figtree

  • December 17, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Women's Health

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Epidemiology

  • #3

    Harvard Medical School / Brigham and Women's Hospital
    Harvard Medical School / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Women's Health

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Women's Health

Original Source(s)

Atherosclerosis risk in women with polycystic ovarian syndrome: it’s not just the comorbidities

  • by Katharine A Bate, Gemma A Figtree

  • December 17, 2025

Related Content

Outcomes after using cerebral embolic protection devices during transcatheter aortic valve replacement: an updated meta-analysis

Systemic immune-inflammation index predicts post-thrombectomy outcomes and reveals a mediating role in the association between neurocardiac stress and prognosis: a multicenter study

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes